When the Creation of a Consortium Provides Useful Answers: Experience of The Latin American DILI Network (LATINDILIN)-Reference-Cited by-同舟云学术

When the Creation of a Consortium Provides Useful Answers: Experience of The Latin American DILI Network (LATINDILIN)

Published:2019-02 Issue:2 Volume:13 Page:51-57
ISSN:2046-2484
Container-title:Clinical Liver Disease
language:en
Short-container-title:Clinical Liver Disease

Author:

Bessone Fernando¹,Hernandez Nelia²,Mendizabal Manuel³,Sanchez Adriana²,Paraná Raymundo⁴,Arrese Marco⁵^ORCID,Tagle Martin⁶,Girala Marcos⁷,Lizarzabal Maribel⁸,Carrera Enrique⁹,Brahm Javier⁵,Contreras Fernando¹⁰,Mendez‐Sanchez Nahum¹¹,Santos Genario⁴,Nunes Vinicius⁴,Medina‐Caliz Inmaculada¹²,Parra‐Martinez Cecilio¹²^ORCID,Sanz‐Villanueva Laura¹²^ORCID,Isabel Lucena Maria¹²,Andrade Raul J.¹²

Affiliation:

1. Hospital Provincial del Centenario, University of Rosario School of Medicine Rosario Argentina

2. Hospital de Clínicas Montevideo Uruguay

3. Hospital Universitario Austral Pilar, Buenos Aires Argentina

4. Hospital Universitario Prof. Edgard Santos Salvador de Bahia Brazil

5. Universidad Católica Pontificia de Chile Santiago Chile

6. Clínica Angloamericana Lima Perú

7. Hospital de Clínicas Asunción del Paraguay Paraguay

8. Hospital Universitario de Maracaibo Maracaibo Venezuela

9. Hospital de Especialidades Eugenio Espejo Quito Ecuador

10. Universidad Nacional Pedro Henriquez Santo Domingo República Dominicana

11. Fundación Clínica Médica Sur Mexico City Mexico

12. Unidad de Gestión Clínica de Ap Digestivo y Servicio de Farmacología Clínica, Instituto de Investigación Biomédica de Málaga Hospital Universitario Virgen de la Victoria, Universidad de Málaga Málaga Spain

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cld.778

Reference18 articles.

1. Drug-induced liver injury: recent advances in diagnosis and risk assessment

2. Causality assessment methods in drug induced liver injury: Strengths and weaknesses

3. Building a Spanish Latin American network on drug induced liver injury: Much to get from a joint collaborative initiative;Bessone F;Ann Hepatol,2012

4. Creating an effective clinical registry for rare diseases

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug-induced liver injury in tropical settings;Treatment and Management of Tropical Liver Disease;2025

2. Emerging role of immunotherapy for cancer as a major cause of drug-induced liver injury;Annals of Hepatology;2024-09

3. Drug-induced Liver Injury in Latin America: 10-year Experience of the Latin American DILI (LATINDILI) Network;Clinical Gastroenterology and Hepatology;2024-07

4. Risk factors related to significant hepatic inflammation in patients with acute drug-induced liver injury;iLIVER;2024-06

5. Clinical and biochemical characteristics, and outcome in 33 patients with ceftriaxone-induced liver injury;European Journal of Clinical Pharmacology;2024-05-29